1. Avorn J (2011) Learning about the safety of drugs—a half-century of evolution. N Engl J Med 365:2151–2153. doi: 10.1056/NEJMp1110327
2. Food and Drug Administration (2005) Guidance for industry development and use of risk minimization action plans
3. HHS Office of Inspector General (2006) FDA’s monitoring of postmarketing study commitments
4. United States Government Accountability Office (2010) Drug safety: FDA has begun efforts to enhance postmarket safety, but additional actions are needed
5. Food and Drug Administration Drug Safety Oversight Board. In: fda.gov. http://www.fda.gov/AboutFDA/CentersOffices/OfficeofMedicalProductsandTobacco/CDER/ucm082129.htm . Accessed 4 Mar 2012